Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort
Renée T. Fortner(Norwegian Institute of Public Health), Heljä‐Marja Surcel(Finnish Institute for Health and Welfare), Minna Tanner(Tampere University Hospital), Paolo Toniolo(Columbia University Irving Medical Center), Raija Kallio(University of Oulu), Anne Zeleniuch‐Jacquotte(New York University), Eero Pukkala(Tampere University), Kjell Grankvist(Umeå University), Adetunji T. Toriola(Washington University in St. Louis), Heikki Joensuu(Orion Corporation (Finland)), Göran Hallmans(Aalborg University Hospital), Jaana Korpela(University of Turku), Helena Schöck(German Cancer Research Center), Eva Lundin(St. Elizabeth's Hospital), Matti Lehtinen(Karolinska Institutet), Hans-Åke Lakso(Heidelberg University), Rudolf Kaaks(German Cancer Research Center)
Cited by 7
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland
|New England Journal of Medicine|2000|4.1k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k